TD Cowen analyst Ryan Langston downgrades $Humana (HUM.US)$ to a hold rating, and adjusts the target price from $402 to $261.
According to TipRanks data, the analyst has a success rate of 70.6% and a total average return of 3.6% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Humana (HUM.US)$'s main analysts recently are as follows:
The company's future performance is anticipated to hinge on the outcome of their appeal with CMS, although an answer is considered 'unlikely' to be obtained before the commencement of open enrollment.
For 2025, Humana has only 25% of its members currently covered by bonus-qualified plans, a notable decrease from 94% in the previous year. This development has been highlighted as a considerable risk concern for the company's financial performance in 2026, as it falls short of investors' expectations.
Despite Humana's Medicare Advantage plans' capacity for annual repricing and potential yearly enhancements in star ratings, the complexity of the company's overall recovery narrative has increased. Without effective star appeal efforts, the timeline for reclaiming normalized margins could extend past 2027.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.